Other
Oncolytic Virus
0
Pipeline Programs↗
3
Active Trials↗
0
Companies Involved↗
Oncolytic Virus is an early-stage landscape with 0 programs across 0 companies.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
6
clinical trials
Completed1 · 17%
No longer available1 · 17%
Unknown status1 · 17%
Not yet recruiting1 · 17%
Active, not recruiting1 · 17%
Recruiting1 · 17%
Clinical Trials
Trial Activity
6 trials
Intra-tumor Injection of Oncolytic Viruses H101 Combined With or Without Radiotherapy in Refractory/Recurrent Gynecological Malignancies
Active, not recruiting·—·Phase 2·NCT05051696·120 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)